American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
61 hedge funds and large institutions have $439M invested in American Renal Associates Holdings, Inc in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
64% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 14
11% more funds holding
Funds holding: 55 → 61 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
16% less capital invested
Capital invested by funds: $522M → $439M (-$82.5M)
54% less call options, than puts
Call options by funds: $222K | Put options by funds: $483K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
+$28.6M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$3.63M |
| 3 |
AAM
AMI Asset Management
Los Angeles,
California
|
+$2.08M |
| 4 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$1.57M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.1M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$3.42M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
-$2.51M |
| 4 |
Goldman Sachs
New York
|
-$434K |
| 5 |
Barclays
London,
United Kingdom
|
-$408K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $10K | +$11K | +700 | New |
|
|
AIP
52
Ameritas Investment Partners
Lincoln,
Nebraska
| $9K | – | – | – |
|
|
CG
53
Cutler Group
San Francisco,
California
| $7K | +$7.86K | +500 | New |
|
54
Nisa Investment Advisors
St. Louis,
Missouri
| $6K | – | – | – |
|
55
UBS Group
Zurich,
Switzerland
| $5K | -$21.1K | -1,343 | -80% |
|
|
56
Barclays
London,
United Kingdom
| $4K | -$408K | -25,976 | -99% |
|
57
Citigroup
New York
| $4K | -$122K | -7,746 | -96% |
|
|
FDCDDQ
58
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3.89K | – | – | – |
|
|
AG
59
Advisor Group
Phoenix,
Arizona
| $3K | -$848 | -54 | -21% |
|
60
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
|
JCM
61
Jacobi Capital Management
Pittston,
Pennsylvania
| $1K | – | – | – |
|
|
62
American Century Companies
Kansas City,
Missouri
| – | -$3.42M | -184,218 | Closed |
|
|
AIM
63
Acrospire Investment Management
Chicago,
Illinois
| – | -$1K | -48 | Closed |
|
ARA Hedge Fund Activity: Q3 2017 in Review
61 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q3 2017, worth a combined $439M — down 16% from $522M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ARA positions and 2 closed out — a net gain of 6 holders — while 23 added to existing stakes and 14 trimmed.
The largest buyer was Van Berkom & Associates, adding an estimated $28.6M. The largest seller was Fidelity Investments, cutting an estimated $15.1M.
- 61 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q3 2017, up from 55 in Q2 2017.
- Funds reported $439M of American Renal Associates Holdings, Inc stock for Q3 2017, down 16% quarter-over-quarter.
- 8 funds opened new American Renal Associates Holdings, Inc positions in Q3 2017 and 2 closed out, a net change of +6 holders.
- The largest American Renal Associates Holdings, Inc buyer in Q3 2017 was Van Berkom & Associates, an estimated $28.6M added.
- The largest American Renal Associates Holdings, Inc seller in Q3 2017 was Fidelity Investments, an estimated $15.1M sold.
Based on aggregated 13F filings for Q3 2017.